Independent Financial Group LLC Acquires Shares of 13,956 iShares Biotechnology ETF $IBB

Independent Financial Group LLC bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 13,956 shares of the financial services provider’s stock, valued at approximately $2,356,000.

A number of other institutional investors have also modified their holdings of the stock. Dynamic Wealth Strategies LLC boosted its holdings in shares of iShares Biotechnology ETF by 16.6% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock valued at $71,000 after purchasing an additional 60 shares during the period. Flagship Private Wealth LLC increased its holdings in iShares Biotechnology ETF by 2.0% during the 4th quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock worth $521,000 after purchasing an additional 60 shares during the period. Larson Financial Group LLC increased its holdings in iShares Biotechnology ETF by 2.3% during the 4th quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock worth $458,000 after purchasing an additional 60 shares during the period. Webster Bank N. A. raised its position in iShares Biotechnology ETF by 1.0% during the 4th quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock valued at $1,093,000 after purchasing an additional 62 shares in the last quarter. Finally, Choreo LLC raised its position in iShares Biotechnology ETF by 2.2% during the 4th quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock valued at $514,000 after purchasing an additional 65 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 0.1%

Shares of IBB stock opened at $189.76 on Friday. iShares Biotechnology ETF has a twelve month low of $128.84 and a twelve month high of $199.05. The stock has a fifty day simple moving average of $177.79 and a two-hundred day simple moving average of $173.40.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were issued a $0.0238 dividend. This represents a $0.10 annualized dividend and a dividend yield of 0.1%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.